Related Experiment Videos
p53 Mutations in human hepatocellular carcinomas from Germany
S Kress1, U R Jahn, A Buchmann
1German Cancer Research Center, Project Group Tumor Promotion in Liver, Heidelberg.
Cancer Research
|June 1, 1992
Summary
Mutations in the tumor suppressor p53 gene are common in liver cancer. This study found specific p53 gene mutations and allele loss in German hepatocellular carcinoma cases, highlighting their role in liver cancer development.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern.
- Genetic alterations, particularly in the p53 tumor suppressor gene, are frequently observed in HCC development.
Purpose of the Study:
- To investigate the frequency and types of p53 gene aberrations in a cohort of German HCC patients.
- To analyze specific mutation sites and allelic status of the p53 gene in hepatocellular carcinoma.
Main Methods:
- Analysis of p53 gene exons 4-8 using single-strand conformation polymorphism (SSCP) and restriction fragment-length polymorphism (RFLP).
- Sequencing of polymerase chain reaction (PCR) products to confirm mutations.
- Examination of c-Ha-ras gene codons 12 and 61 for mutations.
Main Results:
- Two distinct p53 point mutations were identified: a C:G to T:A transition at a CpG site (codon 257) and a T:A to A:T transversion (codon 273).
- Loss of one p53 allele was observed in one tumor with point mutations and two additional tumors without point mutations.
- No mutations were detected in the c-Ha-ras gene codons 12 or 61 in the analyzed HCC samples.
Conclusions:
- Specific p53 gene mutations and allelic loss are present in German hepatocellular carcinoma.
- These genetic alterations in p53 may contribute to the pathogenesis of liver cancer.
- The absence of c-Ha-ras mutations suggests a specific role for p53 in this cohort.